Evaluation of an Automated Analysis Tool for Prostate Cancer Prediction Using Multiparametric Magnetic Resonance Imaging
Overview
Authors
Affiliations
Objective: To evaluate the diagnostic performance of an automated analysis tool for the assessment of prostate cancer based on multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Methods: A fully automated analysis tool was used for a retrospective analysis of mpMRI sets (T2-weighted, T1-weighted dynamic contrast-enhanced, and diffusion-weighted sequences). The software provided a malignancy prediction value for each image pixel, defined as Malignancy Attention Index (MAI) that can be depicted as a colour map overlay on the original images. The malignancy maps were compared to histopathology derived from a combination of MRI-targeted and systematic transperineal MRI/TRUS-fusion biopsies.
Results: In total, mpMRI data of 45 patients were evaluated. With a sensitivity of 85.7% (with 95% CI of 65.4-95.0), a specificity of 87.5% (with 95% CI of 69.0-95.7) and a diagnostic accuracy of 86.7% (with 95% CI of 73.8-93.8) for detection of prostate cancer, the automated analysis results corresponded well with the reported diagnostic accuracies by human readers based on the PI-RADS system in the current literature.
Conclusion: The study revealed comparable diagnostic accuracies for the detection of prostate cancer of a user-independent MAI-based automated analysis tool and PI-RADS-scoring-based human reader analysis of mpMRI. Thus, the analysis tool could serve as a detection support system for less experienced readers. The results of the study also suggest the potential of MAI-based analysis for advanced lesion assessments, such as cancer extent and staging prediction.
Tang J, Zheng X, Wang X, Mao Q, Xie L, Wang R Technol Health Care. 2024; 32(S1):125-133.
PMID: 38759043 PMC: 11191472. DOI: 10.3233/THC-248011.
PI-RADS: introducing a new human-in-the-loop AI model for prostate cancer diagnosis based on MRI.
Yu R, Jiang K, Bao J, Hou Y, Yi Y, Wu D Br J Cancer. 2023; 128(6):1019-1029.
PMID: 36599915 PMC: 10006083. DOI: 10.1038/s41416-022-02137-2.
Vittori G, Bacchiani M, Grosso A, Raspollini M, Giovannozzi N, Righi L World J Urol. 2023; 41(2):435-441.
PMID: 36595077 DOI: 10.1007/s00345-022-04275-x.
Sauck A, Keller I, Hainc N, Pfofe D, Najafi A, John H Tomography. 2022; 8(4):2020-2029.
PMID: 36006067 PMC: 9416664. DOI: 10.3390/tomography8040169.
Xing X, Zhao X, Wei H, Li Y Medicine (Baltimore). 2021; 100(3):e23817.
PMID: 33545946 PMC: 7837946. DOI: 10.1097/MD.0000000000023817.